3 Reasons Why The Biopharma M&A Market Is Ready For Takeoff
Mintz biotech M&A lawyer, Matt Gardella, was quoted in MedCity News article “3 Reasons Why The Biopharma M&A Market Is Ready For Takeoff". This article discusses the pace of biopharma M&A in 2023 and the factors driving it.
Source